C

CVRx Inc
NASDAQ:CVRX

Watchlist Manager
CVRx Inc
NASDAQ:CVRX
Watchlist
Price: 8.22 USD 3.79% Market Closed
Market Cap: 215.4m USD

CVRx Inc
EPS (Diluted)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

CVRx Inc
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
C
CVRx Inc
NASDAQ:CVRX
EPS (Diluted)
-$2
CAGR 3-Years
-8%
CAGR 5-Years
-28%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
EPS (Diluted)
$5
CAGR 3-Years
0%
CAGR 5-Years
17%
CAGR 10-Years
6%
Boston Scientific Corp
NYSE:BSX
EPS (Diluted)
$1
CAGR 3-Years
64%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
Stryker Corp
NYSE:SYK
EPS (Diluted)
$7
CAGR 3-Years
6%
CAGR 5-Years
10%
CAGR 10-Years
9%
Abbott Laboratories
NYSE:ABT
EPS (Diluted)
$8
CAGR 3-Years
21%
CAGR 5-Years
34%
CAGR 10-Years
10%
Intuitive Surgical Inc
NASDAQ:ISRG
EPS (Diluted)
$7
CAGR 3-Years
26%
CAGR 5-Years
21%
CAGR 10-Years
17%
No Stocks Found

CVRx Inc
Glance View

Market Cap
215.3m USD
Industry
Health Care

CVRx, Inc. develops proprietary active implantable technology to treat high blood pressure and heart failure. The company is headquartered in Minneapolis, Minnesota and currently employs 109 full-time employees. The company went IPO on 2021-06-30. The firm is focused on developing, manufacturing and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its platform technology offers BAROSTIM, designed to control the brain to address the imbalance of the autonomic nervous system (ANS), which causes heart failure (HF) and other cardiovascular diseases. The Company’s product, BAROSTIM NEO, is a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction (HFrEF). BAROSTIM NEO provides baroreflex activation therapy (BAT) by sending imperceptible and persistent electrical pulses to baroreceptors located in the wall of the carotid artery to signal the brain to modulate cardiovascular function. BAROSTIM NEO consists of two implantable components, an implantable pulse generator (IPG) and a stimulation lead.

CVRX Intrinsic Value
HIDDEN
Show

See Also

What is CVRx Inc's EPS (Diluted)?
EPS (Diluted)
-2.7 USD

Based on the financial report for Dec 31, 2024, CVRx Inc's EPS (Diluted) amounts to -2.7 USD.

What is CVRx Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
-28%

Over the last year, the EPS (Diluted) growth was -33%. The average annual EPS (Diluted) growth rates for CVRx Inc have been -8% over the past three years , -28% over the past five years .

Back to Top